Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03256695 · COMPLETED
Trial details
- NCT number
- NCT03256695
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2018-04-17
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.